144 related articles for article (PubMed ID: 33571371)
1. Endosalpingiosis Is Negative for GATA3.
White MJ; Vang R; Argani P; Cimino-Mathews A
Arch Pathol Lab Med; 2021 Nov; 145(11):1448-1452. PubMed ID: 33571371
[TBL] [Abstract][Full Text] [Related]
2. Endosalpingiosis in axillary lymph nodes: a possible pitfall in the staging of patients with breast carcinoma.
Corben AD; Nehhozina T; Garg K; Vallejo CE; Brogi E
Am J Surg Pathol; 2010 Aug; 34(8):1211-6. PubMed ID: 20631604
[TBL] [Abstract][Full Text] [Related]
3. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
Djordjevic B; Malpica A
Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
[TBL] [Abstract][Full Text] [Related]
4. Benign müllerian glandular inclusions in men undergoing pelvic lymph node dissection.
Gallan AJ; Antic T
Hum Pathol; 2016 Nov; 57():136-139. PubMed ID: 27438608
[TBL] [Abstract][Full Text] [Related]
5. Two rare cases of endosalpingiosis in the axillary sentinel lymph nodes: evaluation of immunohistochemical staining and one-step nucleic acid amplification (OSNA) assay in patients with breast cancer.
Shiino S; Yoshida M; Jimbo K; Asaga S; Takayama S; Maeshima A; Tsuda H; Kinoshita T; Hiraoka N
Virchows Arch; 2019 May; 474(5):633-638. PubMed ID: 30756183
[TBL] [Abstract][Full Text] [Related]
6. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H
Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes.
Shaoxian T; Baohua Y; Xiaoli X; Yufan C; Xiaoyu T; Hongfen L; Rui B; Xiangjie S; Ruohong S; Wentao Y
J Clin Pathol; 2017 Nov; 70(11):926-934. PubMed ID: 28428285
[TBL] [Abstract][Full Text] [Related]
8. Endosalpingiosis in axillary lymph nodes simulating metastatic breast carcinoma: a potential diagnostic pitfall.
Salehi AH; Omeroglu G; Kanber Y; Omeroglu A
Int J Surg Pathol; 2013 Dec; 21(6):610-2. PubMed ID: 24021901
[TBL] [Abstract][Full Text] [Related]
9. GATA3 immunohistochemistry expression in histologic subtypes of primary breast carcinoma and metastatic breast carcinoma cytology.
Deftereos G; Sanguino Ramirez AM; Silverman JF; Krishnamurti U
Am J Surg Pathol; 2015 Sep; 39(9):1282-9. PubMed ID: 26274030
[TBL] [Abstract][Full Text] [Related]
10. A subset of nondescript axillary lymph node inclusions have the immunophenotype of endosalpingiosis.
Carney E; Cimino-Mathews A; Argani C; Kronz J; Vang R; Argani P
Am J Surg Pathol; 2014 Dec; 38(12):1612-7. PubMed ID: 24921637
[TBL] [Abstract][Full Text] [Related]
11. GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas.
Cimino-Mathews A; Subhawong AP; Illei PB; Sharma R; Halushka MK; Vang R; Fetting JH; Park BH; Argani P
Hum Pathol; 2013 Jul; 44(7):1341-9. PubMed ID: 23375642
[TBL] [Abstract][Full Text] [Related]
12. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors.
Miettinen M; McCue PA; Sarlomo-Rikala M; Rys J; Czapiewski P; Wazny K; Langfort R; Waloszczyk P; Biernat W; Lasota J; Wang Z
Am J Surg Pathol; 2014 Jan; 38(1):13-22. PubMed ID: 24145643
[TBL] [Abstract][Full Text] [Related]
13. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
Shield PW; Papadimos DJ; Walsh MD
Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
[TBL] [Abstract][Full Text] [Related]
14. Wnt Family Member 9b (Wnt9b) Is a New Sensitive and Specific Marker for Breast Cancer.
Lu S; Yakirevich E; Yang D; Xiao Y; Wang LJ; Wang Y
Am J Surg Pathol; 2021 Dec; 45(12):1633-1640. PubMed ID: 34324458
[TBL] [Abstract][Full Text] [Related]
15. Utility of uroplakin II expression as a marker of urothelial carcinoma.
Tian W; Guner G; Miyamoto H; Cimino-Mathews A; Gonzalez-Roibon N; Argani P; Li X; Sharma R; Subhawong AP; Rezaei K; Bivalacqua TJ; Epstein JI; Bishop JA; Netto GJ
Hum Pathol; 2015 Jan; 46(1):58-64. PubMed ID: 25449628
[TBL] [Abstract][Full Text] [Related]
16. Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation.
Mohanty SK; Kim SA; DeLair DF; Bose S; Laury AR; Chopra S; Mertens RB; Dhall D
Mod Pathol; 2016 Aug; 29(8):788-98. PubMed ID: 27125358
[TBL] [Abstract][Full Text] [Related]
17. Axillary Lymph Node Inclusions.
Cimino-Mathews A
Surg Pathol Clin; 2018 Mar; 11(1):43-59. PubMed ID: 29413659
[TBL] [Abstract][Full Text] [Related]
18. Mesothelial cell inclusions in pelvic and para-aortic lymph nodes: a clinicopathologic analysis.
Kim HS; Yoon G; Lee YY; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS; Song SY
Int J Clin Exp Pathol; 2015; 8(5):5318-26. PubMed ID: 26191233
[TBL] [Abstract][Full Text] [Related]
19. Florid, papillary endosalpingiosis of the axillary lymph nodes.
Stolnicu S; Preda O; Kinga S; Marian C; Nicolau R; Andrei S; Nicolae A; Nogales FF
Breast J; 2011; 17(3):268-72. PubMed ID: 21477174
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer.
Pargaonkar AS; Beissner RS; Snyder S; Speights VO
Arch Pathol Lab Med; 2003 Jun; 127(6):701-5. PubMed ID: 12741893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
